Interestingly, rearrangements and amplification of the MAP3K8 gene leading to increased levels of the truncated, active form of this protein are detected in approximately 15% of melanomas without driver mutations, such as BRAF, NRAS, or NF1 [79]. The gene discussed is MAP3K8; the disease is melanoma.